Vedolizumab 68225-0240
Product NDC
68225-0240- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- May 20, 2014
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Vedolizumab | 300 mg/5mL |
Packaging Options(1)
100 VIAL, SINGLE-DOSE in 1 TRAY (68225-240-00) / 5 mL in 1 VIAL, SINGLE-DOSE